{
    "clinical_study": {
        "@rank": "95852", 
        "acronym": "TDEP", 
        "arm_group": [
            {
                "arm_group_label": "Theta-Burst Stimulation", 
                "arm_group_type": "Experimental", 
                "description": "Theta-Burst protocol for transcranial magnetic stimulation on dorsolateral prefrontal cortex (exact location to be determined using neuronavigation guided by Magnetic Resonance Imaging)"
            }, 
            {
                "arm_group_label": "High Frequency stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "High frequency Transcranial Magnetic Stimulation using the standard protocol for depression, on left dorsolateral prefrontal cortex."
            }
        ], 
        "brief_summary": {
            "textblock": "This research programme purports to test the effectiveness of two Transcranial Magnetic\n      Stimulation (TMS) protocols (Repetitive high frequency protocol and Theta Burst protocol)\n      in reducing the symptoms of depression. The study also uses Magnetic Resonance Imaging (MRI)\n      scans to improve the localization of TMS targets."
        }, 
        "brief_title": "A Randomized Study of Transcranial Magnetic Stimulation in the National Health Service, United Kingdom .", 
        "condition": "Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of depressive disorder (DSM-IV)\n\n          -  Diagnosis of treatment resistance (at least stage 1 as defined by Thase & Rush, 1997\n             for depression)\n\n          -  Female or male between 18 and 70 years\n\n        Exclusion Criteria:\n\n          -  History of Bipolar disorder\n\n          -  Clinically relevant neurological comorbidity such as brain neoplasm, cerebral\n             vascular events, epilepsy, neurodegenerative disorders, prior brain surgery\n\n          -  Metal objects in and around body that cannot be removed\n\n          -  Pregnancy\n\n          -  Cardiac pacemaker or implanted medication pump\n\n          -  Major unstable medical illness\n\n          -  Change in prescribed medication in the 2 weeks preceding the start of TMS trial\n\n          -  Current alcohol/stimulant dependence with propensity for toxic/withdrawal seizures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "124", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02016456", 
            "org_study_id": "AMH/021213"
        }, 
        "intervention": [
            {
                "arm_group_label": "Theta-Burst Stimulation", 
                "description": "At 80% motor threshold determined using single pulse stimuli. Depending on the hemisphere determined by connectivity analysis and neuronavigation in each individual, either continuous (left prefrontal) or intermittent (right prefrontal) train of pulses will be delivered.", 
                "intervention_name": "Theta-Burst Stimulation", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "High Frequency stimulation", 
                "description": "Left prefrontal stimulation. 120% motor threshold with a pulse sequence of 10 Hz for 4 seconds, followed by a 26 second quiet period. Treatment will last for a total of 37.5 minutes this is a total of 3,000 pulses", 
                "intervention_name": "High frequency stimulation", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Transcranial Magnetic Stimulation", 
            "Neuronavigation", 
            "Magnetic Resonance Imaging"
        ], 
        "lastchanged_date": "December 15, 2013", 
        "link": {
            "url": "http://www.nlm.nih.gov/medlineplus/depression.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Nottingham", 
                    "country": "United Kingdom", 
                    "state": "England", 
                    "zip": "NG2 7UH"
                }, 
                "name": "Neuromodulation Unit, Nottinghamshire Healthcare NHS Trust"
            }, 
            "investigator": {
                "last_name": "Sudheer Lankappa, MRCPsych", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Transcranial Magnetic Stimulation to Treat Depression", 
        "other_outcome": [
            {
                "measure": "Change in processing speed (using modified digit-symbol test) scores", 
                "safety_issue": "No", 
                "time_frame": "4 weeks and 3 months"
            }, 
            {
                "measure": "Change in Clinical Global Impression scores", 
                "safety_issue": "No", 
                "time_frame": "4 weeks and 3 months"
            }, 
            {
                "measure": "Change in Social and Occupational Functioning Assessment  scores", 
                "safety_issue": "No", 
                "time_frame": "4  weeks and 3 months"
            }
        ], 
        "overall_contact": {
            "email": "Sudheer.Lankappa@nottshc.nhs.uk", 
            "last_name": "Sudheer Lankappa, MRCPsych", 
            "phone": "44 115 9691300"
        }, 
        "overall_official": {
            "affiliation": "Nottinghamshire Healthcare NHS Trust", 
            "last_name": "Sudheer Lankappa, MRCPsych", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Health Service", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of responders defined as subjects with 50% reduction in the 17-item Hamilton Depression Scale Score", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02016456"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Institute of Mental Health Nottingham", 
            "investigator_full_name": "Sudheer Lankappa", 
            "investigator_title": "Consultant Psychiatrist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Mean change in Beck Depression Inventory scores", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Institute of Mental Health Nottingham", 
        "sponsors": {
            "collaborator": {
                "agency": "Nottinghamshire Healthcare NHS Trust", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Institute of Mental Health Nottingham", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}